LON:INDV - Indivior Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started GBX 335.40 -11.40 (-3.29 %) (As of 07/22/2018 03:55 PM ET)Previous CloseGBX 335.40Today's RangeGBX 334.50 - GBX 34952-Week RangeGBX 246.50 - GBX 436.60Volume4.70 million shsAverage Volume2.44 million shsMarket Capitalization£2.93 billionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileAnalyst RatingsInsider TradesHeadlinesChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, overdose rescue, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in Richmond, Virginia. Receive INDV News and Ratings via Email Sign-up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Drugs - Generic Sub-IndustryN/A SectorMedical SymbolLON:INDV CUSIPN/A Webindivior.com Phone+44-1753-217800 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-54.72% Return on EquityN/A Return on Assets-41.38% Miscellaneous EmployeesN/A Outstanding Shares721,460,000Market Cap£2,930.00 Indivior (LON:INDV) Frequently Asked Questions What is Indivior's stock symbol? Indivior trades on the London Stock Exchange (LON) under the ticker symbol "INDV." What price target have analysts set for INDV? 6 analysts have issued 1-year price targets for Indivior's shares. Their predictions range from GBX 365 to GBX 600. On average, they anticipate Indivior's stock price to reach GBX 476.33 in the next year. This suggests a possible upside of 42.0% from the stock's current price. View Analyst Ratings for Indivior. What is the consensus analysts' recommendation for Indivior? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Who are some of Indivior's key competitors? Some companies that are related to Indivior include Smith & Nephew (SN), Henry Schein (HSIC), WellCare Health Plans (WCG), Hologic (HOLX), Seattle Genetics (SGEN), Cochlear (COH), Varian Medical Systems (VAR), Alnylam Pharmaceuticals (ALNY), Jazz Pharmaceuticals (JAZZ), Universal Health Services, Inc. Class B (UHS), Genmab A/S (GNMSF), WILLIAM DEMANT/ADR (WILYY), STRAUMANN Hldg/ADR (SAUHY), Perrigo (PRGO) and DENTSPLY SIRONA (XRAY). Who are Indivior's key executives? Indivior's management team includes the folowing people: Mr. Shaun Thaxter, CEO & Exec. DirectorMr. Mark Crossley, CFO & Exec. DirectorDr. Christian Heidbreder, Chief Scientific OfficerMr. Ingo Elfering, Chief Information & Innovation OfficerMr. Javier Rodriguez, Chief Legal Officer Has Indivior been receiving favorable news coverage? News headlines about INDV stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Indivior earned a coverage optimism score of 0.06 on Accern's scale. They also gave news coverage about the specialty pharmaceutical company an impact score of 47.27 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days. How do I buy shares of Indivior? Shares of INDV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Indivior's stock price today? One share of INDV stock can currently be purchased for approximately GBX 335.40. How big of a company is Indivior? Indivior has a market capitalization of £2.93 billion. How can I contact Indivior? Indivior's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-1753-217800. MarketBeat Community Rating for Indivior (LON INDV)Community Ranking: 3.4 out of 5 ( )Outperform Votes: 371 (Vote Outperform)Underperform Votes: 167 (Vote Underperform)Total Votes: 538MarketBeat's community ratings are surveys of what our community members think about Indivior and other stocks. Vote "Outperform" if you believe INDV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INDV will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/22/2018 by MarketBeat.com StaffFeatured Article: What does RSI mean?